Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP834190.RABaTFvBDx9SWdXhpHud98aV7GbXCXpz_4QRLizcDd4xQ130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP834190.RABaTFvBDx9SWdXhpHud98aV7GbXCXpz_4QRLizcDd4xQ130_provenance.
• NP293459.RAcd5v76RThCggSW5kr1EKV5TH0Mf_ku74GVVpU44cvh4130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293459.RAcd5v76RThCggSW5kr1EKV5TH0Mf_ku74GVVpU44cvh4130_provenance.
• NP591619.RAff7wBmSmPpKqYQJ8pcrBsOhOfxiQqzzUwl9Rsq0t4X8130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591619.RAff7wBmSmPpKqYQJ8pcrBsOhOfxiQqzzUwl9Rsq0t4X8130_provenance.
• NP881919.RArCd9270w5KMF5P3O3wyX-bJSl42YLlF9AHOmbsz8rjs130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881919.RArCd9270w5KMF5P3O3wyX-bJSl42YLlF9AHOmbsz8rjs130_provenance.
• assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP971589.RAsgxDzlhycNIJ-OqFvBhNAg4qcjCkbbeND9rSMEkJtH0130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971589.RAsgxDzlhycNIJ-OqFvBhNAg4qcjCkbbeND9rSMEkJtH0130_provenance.
• NP988284.RAt7-q4C4fDSabBpPDL7Oiemk219bxScKVQMinra-SCp4130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP988284.RAt7-q4C4fDSabBpPDL7Oiemk219bxScKVQMinra-SCp4130_provenance.
• NP424829.RAksegV6Sn8G2veXICCIHUDeCb_RAZcBv2CdL7RbnwQzM130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424829.RAksegV6Sn8G2veXICCIHUDeCb_RAZcBv2CdL7RbnwQzM130_provenance.
• NP424830.RAhvF-icIlh8sxrBnS0CGzLpnjnXsoHAv80fXFyeEGNKE130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424830.RAhvF-icIlh8sxrBnS0CGzLpnjnXsoHAv80fXFyeEGNKE130_provenance.
• NP424831.RAvXi-ffpbE_8Yn_3hwnagY1rAnikKfZ4J4W_DagVQAtw130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424831.RAvXi-ffpbE_8Yn_3hwnagY1rAnikKfZ4J4W_DagVQAtw130_provenance.
• NP424833.RAOtckz-Xlt7a0OILf4WBEqudmCXvfMAKUVG3XSftz6eg130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424833.RAOtckz-Xlt7a0OILf4WBEqudmCXvfMAKUVG3XSftz6eg130_provenance.
• NP988443.RAxFZbLimmkU-Y7b7mi7kTq-bzig1MRS5kWEL4ZfoYFHs130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP988443.RAxFZbLimmkU-Y7b7mi7kTq-bzig1MRS5kWEL4ZfoYFHs130_provenance.
• NP971749.RA2706al1BRwcjSfG37GoBxL0VfwC2Z_WUL5kjFf4QUEc130_assertion description "[Using FISH, GST-pi amplification is a common event in head and neck squamous cell carcinoma and may be associated with cisplatin resistance and poor clinical outcomes in head and neck cancer patients treated with cisplatin-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971749.RA2706al1BRwcjSfG37GoBxL0VfwC2Z_WUL5kjFf4QUEc130_provenance.